Výsledky vyhledávání

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

Autor: Alex C. Spyropoulos, Jaya Prakash Rao, Gregory Piazza, Chiara Sugarmann, Elliot S. Barnathan, Eunyoung Suh, Concetta Lipardi, Scott Bull, Warren H. Capell, Marc P. Bonaca, William R. Hiatt, Judith Hsia

Publikováno v: American Heart Journal

Background COVID-19 is associated with both venous and arterial thrombotic complications. While prophylactic anticoagulation is now widely recommended for hospitalized patients with COVID-19, the effectiveness and safety of thromboprophylaxis in outp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745c25114489dea73ca8addaaf2243b2

Zobrazit plný text záznamu

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

Publikováno v: Journal of the American Society of Nephrology, 31(5), 1128-1139. AMER SOC NEPHROLOGY
J Am Soc Nephrol

BACKGROUND: Canagliflozin reduced renal and cardiovascular events in people with type 2 diabetes in the CREDENCE trial. We assessed efficacy and safety of canagliflozin by initial estimated glomerular filtration rate (eGFR). METHODS: CREDENCE randoml

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75cc49e0de93f3c4191f2b4825756550
https://research.rug.nl/en/publications/05e58d3f-d008-43f7-9d77-9bc4dfb474fe

Zobrazit plný text záznamu

Concept Elicitation Within Patient-Powered Research Networks: A Feasibility Study in Chronic Lymphocytic Leukemia

Autor: Sarah Fleming, David Cella, Paul Wicks, K.P. McCarrier, Renee Pierson, Kristina Simacek, Scott Bull

Publikováno v: Value in Health. 19(1):42-52

Objectives To explore the feasibility of using social media–based patient networks to gather qualitative data on patient-reported outcome (PRO) concepts relevant to chronic lymphocytic leukemia (CLL). Methods Between August and November 2013, US-re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405dd0e9d592782867daa1722c698fe0

Zobrazit plný text záznamu

33.4: Flexible IGZO TFTs with a Disruptive Photo-patternable and Thermally Stable Organic Gate Insulator

Autor: Cheng-Wei Chou, Shiuan-Iou Lin, Yu Xia, Su Jin Kang, Wan-Yu Hung, Antonio Facchetti, Scott Bull, Chung-Chin Hsiao, Hsing-Hung Hsieh, William C. Sheets

Publikováno v: SID Symposium Digest of Technical Papers. 46:486-489

A new photo-patternable and thermally-stable organic gate insulator has been developed specifically for IGZO TFTs. Combined with an optimized device platform, flexible IGZO TFTs show groundbreaking performance such as high field-effect mobilities, ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0f29899986fe34b2e2e62372f8d5612
https://doi.org/10.1002/sdtp.10435

Zobrazit plný text záznamu

Validity of the Patient-Reported Clinical Global Impression of Change as a Measure of Treatment Response in Men with Premature Ejaculation

Autor: Joseph W. Aquilina, Fisseha Tesfaye, Raymond C. Rosen, Stanley E. Althof, Gerald B. Brock, David L. Rowland, Scott Bull, Margaret Rothman

Publikováno v: The Journal of Sexual Medicine. 7:2243-2252

Introduction The Clinical Global Impression of Change (CGIC) measures have high utility in clinical practice. However, it is unknown whether the CGIC is valued for assessing premature ejaculation (PE) symptoms and/or the relationship between CGIC and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c48b1ded1c6987201de8dc99e1fd286
https://doi.org/10.1111/j.1743-6109.2010.01793.x

Zobrazit plný text záznamu

Baseline Characteristics and Treatment Outcomes for Men with Acquired or Lifelong Premature Ejaculation with Mild or No Erectile Dysfunction: Integrated Analyses of Two Phase 3 Dapoxetine Trials

Autor: Scott Bull, Ira D. Sharlip, Stanley E. Althof, Joseph W. Aquilina, Chris McMahon, Fisseha Tesfaye, Hartmut Porst, David Rivas

Publikováno v: The Journal of Sexual Medicine. 7:2231-2242

Introduction Premature ejaculation (PE) is classified as an acquired or lifelong condition but data on baseline characteristics and response to treatment of men with acquired or lifelong PE and mild erectile dysfunction (ED) or normal erectile functi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d13b3f9bf19140a2477a38d24bf826c
https://doi.org/10.1111/j.1743-6109.2010.01820.x

Zobrazit plný text záznamu

Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine

Autor: Scott Bull, Ridwan Shabsigh, Margaret Rothman, Fisseha Tesfaye, David L. Rowland, Donald L. Patrick

Publikováno v: BJU International. 102:824-828

OBJECTIVES To assess the utility of perceived control over ejaculation (‘control’) in the evaluation of treatment benefit in men with premature ejaculation (PE), and to compare effects associated with a two-category or greater increase in this va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6ec6d2d023ce7ff576646d6e62acfb
https://doi.org/10.1111/j.1464-410x.2008.07845.x

Zobrazit plný text záznamu

Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus

Autor: Wayne Shaw, Maria Alba, Sue Sha, Norm Rosenthal, Rong Qiu, Kirk Ways, William Canovatchel, Mehul Desai, Robert Edwards, Paul Rothenberg, Nicholas A. Di Prospero, Gary Meininger, Dainius Balis, Keith T. Demarest, Scott Bull, Frank Vercruysse, David Polidori

Publikováno v: Annals of the New York Academy of Sciences. 1358

The sodium glucose co-transporter 2 (SGLT2) inhibitor canagliflozin is a novel treatment option for adults with type 2 diabetes mellitus (T2DM). In patients with hyperglycemia, SGLT2 inhibition lowers plasma glucose levels by reducing the renal thres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4749e79b72b0e213d4c8682a4896ba67
https://pubmed.ncbi.nlm.nih.gov/26305874

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání